A significant decrease was identified in the levels of CD1d on monocytes in the PB of AL patients (AML and ALL) compared with the healthy controls (P<0.05; Table II and Fig. 1B–D and G). This evidence concerns the gene CD1D and acute lymphoblastic leukemia.